Intellia Therapeutics, Inc. (NTLA) ownership: Top institutional holder: ARK Investment Management LLC ($186.01M). Insider activity: Net Seller (0 buys, 15 sells). 8 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ARK Investment Management LLC | 14509247.00 | $186.01M | 2026-03-31 |
| BlackRock, Inc. | 12155806.00 | $155.84M | 2026-03-31 |
| VANGUARD GROUP INC | 13010001.00 | $116.96M | 2025-12-31 |
| STATE STREET CORP | 6922676.00 | $88.75M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6223325.00 | $79.78M | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 5728177.00 | $73.44M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5084105.00 | $65.18M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 4705901.00 | $60.33M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-01 | |
| Sell | null | 2026-03-01 | |
| Sell | null | 2026-03-01 | |
| Sell | null | 2026-03-01 | |
| Sell | null | 2026-03-01 | |
| Sell | null | 2026-03-01 |
Back to NTLA overview · NTLA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.